162 related articles for article (PubMed ID: 32759956)
1. Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants.
Euteneuer JC; Kerns E; Leiting C; McCulloh RJ; Peeples ES
J Perinatol; 2021 Jan; 41(1):53-61. PubMed ID: 32759956
[TBL] [Abstract][Full Text] [Related]
2. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.
Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES
Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409
[TBL] [Abstract][Full Text] [Related]
3. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
J Perinatol; 2015 Jan; 35(1):61-6. PubMed ID: 25102319
[TBL] [Abstract][Full Text] [Related]
4. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Backes CH; Reagan PB; Smith CV; Jadcherla SR; Slaughter JL
Hosp Pediatr; 2016 Jan; 6(1):27-33. PubMed ID: 26666265
[TBL] [Abstract][Full Text] [Related]
6. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
[TBL] [Abstract][Full Text] [Related]
7. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
8. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB
Pediatrics; 2013 Apr; 131(4):716-23. PubMed ID: 23478874
[TBL] [Abstract][Full Text] [Related]
9. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
Clouse BJ; Jadcherla SR; Slaughter JL
PLoS One; 2016; 11(2):e0148188. PubMed ID: 26840339
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
12. Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia.
House M; Nathan A; Bhuiyan MAN; Ahlfeld SK
Pediatr Pulmonol; 2021 Aug; 56(8):2589-2596. PubMed ID: 34002957
[TBL] [Abstract][Full Text] [Related]
13. [Respiratory morbidity after hospital discharge in premature infants born at < or = 32 weeks gestation with bronchopulmonary dysplasia].
Pérez Pérez G; Navarro Merino M; Romero Pérez MM; Sáenz Reguera C; Pons Tubío A; Polo Padillo J
An Pediatr (Barc); 2004 Feb; 60(2):117-24. PubMed ID: 14757014
[TBL] [Abstract][Full Text] [Related]
14. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
Nyp MF; Taylor JB; Norberg M; Truog WE
Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
[TBL] [Abstract][Full Text] [Related]
15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
16. The changing relationship between bronchopulmonary dysplasia and cognition in very preterm infants.
Brumbaugh JE; Colaizy TT; Patel NM; Klein JM
Acta Paediatr; 2018 Aug; 107(8):1339-1344. PubMed ID: 29333635
[TBL] [Abstract][Full Text] [Related]
17. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants.
Korhonen P; Tammela O; Koivisto AM; Laippala P; Ikonen S
Early Hum Dev; 1999 Apr; 54(3):245-58. PubMed ID: 10321791
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide.
Qi Y; Jiang Q; Chen C; Cao Y; Qian L
PLoS One; 2013; 8(11):e79060. PubMed ID: 24244420
[TBL] [Abstract][Full Text] [Related]
19. Fluid status in the first 10 days of life and death/bronchopulmonary dysplasia among preterm infants.
Soullane S; Patel S; Claveau M; Wazneh L; Sant'Anna G; Beltempo M
Pediatr Res; 2021 Aug; 90(2):353-358. PubMed ID: 33824447
[TBL] [Abstract][Full Text] [Related]
20. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
